Abiopharma

🔍 Murray Novelette (Executive)

Company: LIQUIDITY SERVICES INC (LQDT)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 548 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: false | shares_owned_after: 36,317.00 | transaction_form_type: 4 | Footnotes: F13
• Sold 548 shares of Common Stock at $43.12 per share (Direct)
  Date: 2026-08-21 | Code: J | equity_swap_involved: false | shares_owned_after: 35,769.00 | transaction_form_type: 4 | Footnotes: F14
• Acquired 486 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: false | shares_owned_after: 36,255.00 | transaction_form_type: 4 | Footnotes: F15
• Sold 486 shares of Common Stock at $43.12 per share (Direct)
  Date: 2026-08-21 | Code: J | equity_swap_involved: false | shares_owned_after: 35,769.00 | transaction_form_type: 4 | Footnotes: F16
• Sold 2,142 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-01-01 | equity_swap_involved: false | shares_owned_after: 1,071.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 4,750 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2029-01-01 | equity_swap_involved: false | shares_owned_after: 3,800.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 2,589 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2027-01-01 | shares_owned_after: 2,589.00 | Footnotes: F1, F9
• Holds 5,355 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2028-01-01 | shares_owned_after: 5,355.00 | Footnotes: F1, F10
• Holds 7,125 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2029-01-01 | shares_owned_after: 7,125.00 | Footnotes: F1, F8
• Holds 10,550 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2030-01-01 | shares_owned_after: 10,550.00 | Footnotes: F1, F12
• Holds 10,550 shares of Restricted Stock Unit Grant (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2030-01-01 | shares_owned_after: 10,550.00 | Footnotes: F1, F2
• Holds 3,269 shares of Stock Option Grant at $22.2 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2031-12-07 | shares_owned_after: 3,269.00 | Footnotes: F4
• Holds 4,333 shares of Stock Option Grant at $14.0 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2032-12-23 | shares_owned_after: 4,333.00 | Footnotes: F5
• Holds 6,248 shares of Stock Option Grant at $17.31 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2033-12-22 | shares_owned_after: 6,248.00 | Footnotes: F6
• Holds 10,150 shares of Stock Option Grant at $23.5 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2035-10-29 | shares_owned_after: 10,150.00 | Footnotes: F11
• Holds 10,150 shares of Stock Option Grant at $23.5 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2035-10-29 | shares_owned_after: 10,150.00 | Footnotes: F3
• Holds 6,745 shares of Stock Option Grant at $21.62 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2034-10-30 | shares_owned_after: 6,745.00 | Footnotes: F7
• Holds 1,732 shares of Stock Option Grant at $17.31 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2033-12-22 | shares_owned_after: 1,732.00 | Footnotes: F3
• Holds 5,600 shares of Stock Option Grant at $21.62 per share (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2034-10-30 | shares_owned_after: 5,600.00 | Footnotes: F3

Footnotes:

• F1: Each restricted stock unit is the economic equivalent of one share of Liquidity Services, Inc. Common Stock.
• F2: These restricted stock units will vest, if at all, based on the Issuer's achievement of certain financial milestones.
• F3: These options become exercisable, if at all, based on the Issuer's achievement of certain financial milestones.
• F4: 12/48th of this option grant vested on January 1, 2023 and thereafter, an additional 1/48th will vest each month for thirty-six months.
• F5: 12/48th of this option grant vested on January 1, 2024 and thereafter, an additional 1/48th will vest each month for thirty-six months.
• F6: 12/48th of this option grant vested on January 1, 2025 and thereafter, an additional 1/48th will vest each month for thirty-six months.
• F7: 12/48th of this option grant will vest on January 1, 2026 and thereafter, an additional 1/48th will vest each month for thirty-six months.
• F8: Twenty-five percent of this restricted stock unit grant vests on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029.
• F9: Twenty-five percent of this restricted stock unit grant vests on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027.
• F10: Twenty-five percent of this restricted stock unit grant vests on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028.
• F11: 12/48th of this option grant will vest on January 1, 2027, and, thereafter, an additional 1/48th will vest each month for thirty-six months.
• F12: Twenty-five percent of this restricted stock unit grant vests on each of January 1, 2027, January 1, 2028, January 1, 2029 and January 1, 2030.
• F13: Represents the net issuance of 548 shares from the vesting of 1,071 restricted stock units from which the federal and state withholding due at the vesting of such restricted stock units was satisfied by the issuer withholding 523 shares.
• F14: In accordance with the Issuer's policies, the reporting person elected the following release method with respect to the vesting of restricted stock units: shares are withheld to cover taxes and remaining shares are sold. The sale proceeds are used to cover fees and the balance is received by the reporting person in cash. This transaction reflects the sale of the 548 shares received by the reporting person in connection with the vesting of 1,071 restricted stock units.
• F15: Represents the net issuance of 486 shares from the vesting of 950 restricted stock units from which the federal and state withholding due at the vesting of such restricted stock units was satisfied by the issuer withholding 464 shares.
• F16: In accordance with the Issuer's policies, the reporting person elected the following release method with respect to the vesting of restricted stock units: shares are withheld to cover taxes and remaining shares are sold. The sale proceeds are used to cover fees and the balance is received by the reporting person in cash. This transaction reflects the sale of the 486 shares received by the reporting person in connection with the vesting of 950 restricted stock units.